
物理性质
- 熔点-84 °C
- 沸点116.5±8.0 °C at 760 mmHg
- 闪点13.3±0.0 °C
- 密度0.8±0.1 g/cm3
- PSA:17.07
- LogP:1.25
- 折射率1.393
- 蒸汽压18.2±0.2 mmHg at 25°C
- 溶解性水:可溶20g/L
- 敏感性1.能与乙醇、乙醚、苯等大多数有机溶剂和动植物油相混溶。是硝酸纤维素、聚氯乙烯、聚乙酸乙烯酯、聚苯乙烯、环氧树脂、天然及合成橡胶、DDT、2,4-D以及许多有机物的优良溶剂。能配制成低黏度溶液,防止凝胶化。2.化学性质:分子中羰基及邻接的氢原子富有化学反应性,化学性质与丁酮相似。例如用铬酸等强氧化剂氧化时,生成乙酸、异丁酸、异戊酸、二氧化碳和水。催化加氢得到4-甲基-2-戊醇。与亚硫酸氢钠生成加成产物。在碱性催化剂存在下,与其他羰基化合物发生缩合反应。与肼缩合生成腙,与乙酸乙酯发生Claisen缩合反应。3.稳定性 稳定4.禁配物 强氧化剂、强还原剂、强碱5.聚合危害 不聚合
- 外观形态透明液体
- 储存条件储存注意事项储存于阴凉、通风的库房。远离火种、热源。库温不宜超过37°C。保持容器密封保存。应与氧化剂、还原剂、碱类分开存放,切忌混储。采用防爆型照明、通风设施。禁止使用易产生火花的机械设备和工具。储区应备有泄漏应急处理设备和合适的收容材料。
- 产品应用用作喷漆,硝基纤维,某些纤维醚,樟脑,油脂,天然和合成橡胶的溶剂.
- 性质描述无色稳定可燃液体,有愉快气味.凝固点-84°C(-80.4°C),沸点116.8°C,相对密度0.8020(20/4°C),折射率1.3962,闪点22.78°C,自然点460°C.能与醇,苯,乙醚及多数有机溶剂混溶,微溶于水.蒸气与空气形成爆炸性混合物,爆炸极限1.4-7.5(体积).
MSDS等安全信息
- GHS象形图



- GHS符号GHS02 & GHS08 & GHS07;
注释: Flame & Health hazard & Exclamation mark - 危险类别易燃液体 类别2
致癌性 类别2
急性毒性 类别4(吸入)
特定目标器官毒性 - 单次接触 类别3
严重眼刺激 类别2
急性毒性 类别3(吸入)
急性毒性 类别4(经口)
吸入危害 类别1
生殖毒性 类别2
急性毒性 类别4(经皮)
皮肤腐蚀/刺激 类别2
水生慢性毒性 类别2
特定目标器官毒性-重复接触 类别1
严重眼刺激 类别2A - 警示词Danger(危险)
- 危险描述H225 |高度易燃液体和蒸气.
H351 |怀疑致癌.
H332 |吸入有害.
H335 |可能引起呼吸道刺激.
H336 |可能引起嗜睡或头晕.
H319 |造成严重眼刺激.
H331 |吸入会中毒.
H302 |吞咽有害.
H304 |吞咽并进入呼吸道可能致命.
H361 |怀疑对生育能力或胎儿造成损害.
H312 |皮肤接触有害.
H315 |造成皮肤刺激.
H411 |对水生生物有毒并具有长期持续影响.
H370 |损害器官.
H372 |长期或反复接触损害器官. - 防范说明P203, P210, P233, P240, P241, P242, P243, P261, P264+P265, P271, P280, P303+P361+P353, P304+P340, P305+P351+P338, P317, P318, P319, P337+P317, P370+P378, P403+P233, P403+P235, P405, and P501
- 危险等级3
- UN编号1245.0
- 危险品标志F:Flammable
- 包装等级II
- 安全声明S9-S16-S29-S45-S36/37-S7
- 危险类别码R66,R36/37,R11,R20
- WGK Germany1
欧盟法规
统一分类与标签压力设备指令-第1组危险流体REACH注册ECHA物质欧盟气雾剂指令-标签制度食品接触材料-禁用CMR物质C&L通报REACH预注册废弃物危险特性清单欧盟化学物质指示性职业接触限值工作场所安全标识要求ECHA物质化妆品禁用物质清单上下游产品
CAS号108-11-2 甲基异丁基甲醇(MIBC) | CAS号105-44-2 4-甲基-2-戊酮肟 | CAS号67-64-1 丙酮 | CAS号67-63-0 异丙醇 | CAS号141-79-7 异丙叉丙酮 | CAS号123-72-8 正丁醛 | CAS号5660-53-7 1, 3-Dioxolane-... | CAS号503-74-2 异戊酸 | CAS号64-19-7 冰醋酸 | CAS号2035-08-7 2-methyl-2-(2-m... | CAS号10595-60-5 N,N'-bis(1,3-di... | CAS号1119-29-5 Pentanamide, 4-... | CAS号1112-78-3 2,2-dimethoxy-4... | CAS号105-51-1 2-Pentanamine,N... | CAS号40836-01-9 氯化2,4,6-三苯基吡喃嗡 | CAS号34036-16-3 5-甲基-3-羰基己酸乙酯 | CAS号57808-66-9 多潘立酮 | CAS号103-82-2 苯乙酸合成工艺路线路线简述
- 合成目标产物 4-Methyl-2-Pentanone 主要起始原料 2-Methyl-2-(2-Methylpropyl)-1,3-Dioxolane
- (文献来源)合成步骤主要原料 2-Methyl-2-(2-Methylpropyl)-1,3-Dioxolane
4-甲基-2-戊醇置于iron(III) Chloride Hexahydrate,氧气,Silica Gel,2,2,6,6-四甲基哌啶氧化物体系中,用 甲苯 用作溶剂,80.0 °C,500.01 Kpa 条件下,反应 90.08H,以90%的收率获得4-甲基-2-戊酮
参考文献:硅胶存在下六水合氯化铁/ Tempo催化的醇的选择性好氧氧化
标题:硅胶存在下六水合氯化铁/ Tempo催化的醇的选择性好氧氧化
摘要:在硅胶存在下,使用分子印迹技术完成了fecl 3 •6H 2 O / 2,2,6,6-四甲基哌啶n-氧基(tempo)催化的醇氧化为相应的醛和酮的环保,高效过程氧气或空气作为终端氧化剂.缺电子的苯甲醇被平滑氧化为相应的醛,分离产率高达99%.发现硅胶不仅可以提高催化反应速率,而且可以提高产物的选择性.Fecl 3 •6H 2的高性能硅胶存在下的o / Tempo催化剂体系可能归因于表面硅烷醇基团.紫外可见光谱分析表明,Fe(III)-Tempo配合物可作为本催化体系中的活性中间物质.提出了催化系统的合理机理.版权所有©2012 John Wiley&sons,Ltd.
Doi:10.1002/aoc.1862
海关参考信息
- 2912110000-甲醛
2912120000-乙醛
2914110000-丙酮
2914120000-丁酮 - 💡 提示:海关信息按照顺序优先匹配,如需确认的海关信息,请参考相关资料。
- 详情请参考:📖 海关编码查询和海关进出口税则
专利信息
专利号:WO-2025104067-A1
优先权日:2023-11-14
标题 :Use of a heterogeneous copper/zinc catalyst for continuous, gas-phase synthesis of methyl isobutyl ketone and/or methyl isobutyl carbinol by hydrogenation of mesityl oxide
发明人:RUPPIN CHRISTOPHE
权利人:ARKEMA FRANCE
摘要:The present invention relates to the use of a catalyst comprising a mixture of copper and zinc for continuous, gas-phase synthesis of methyl isobutyl ketone (MIBK) and/or methyl isobutyl carbinol (MIBC) from mesityl oxide. The invention also relates to a synthesis method comprising the following sequence of steps: continuous injection of the reagents in gas form through a reactor; hydrogenation reaction under pressure of hydrogen and at a temperature of between 120 and 250°C in the presence of the catalyst; condensation of the stream from the reactor and separation of the gas stream from the liquid stream; and purification of the liquid stream in order to separate the methyl isobutyl ketone and/or the methyl isobutyl carbinol.
专利号:US-9518047-B2
优先权日:2013-10-17
标题 :Process for the industrial synthesis of lurasidone
发明人:ANGELINI TOMMASO; BETTONI PIERGIORGIO; ROLETTO JACOPO; PAISSONI PAOLO
权利人:PROCOS SPA
摘要:Disclosed is a process for the industrial synthesis of Lurasidone from (1R,2R)-cyclohexane-1,2-diyldimethanol (1), 3-(piperazin-1-yl)benzo[d]isothiazole (3) and (3aR,4R,7R,7aS)-3a,4,7,7a-tetrahydro-4,7-methanoisobenzofuran-1,3-dione (6).). Said process is optimised to obtain Lurasidone with high yields and high purities by preparing highly pure synthesis intermediates, using critical raw materials and reagents in amounts close to the stoichiometric amounts, increasing productivity and reducing the costs and environmental impact of the process.
专利号:US-2024247022-A1
优先权日:2021-05-04
标 题 :A Process for Synthesis of Nicotinamide Riboside Chloride (NRCL)
发明人:MALKANNAGARI RAMANI; GUNDAPUNENI RAGHAVA RAO; BOHAN FRODE
权利人:BOHAN & CO AS
摘要:The present invention discloses synthesis of nicotinamide riboside chloride (NRCI). More particularly, the present invention describes cost effective and industrially scalable process for the synthesis of NRCI in amorphous form.
专利号:US-8791287-B2
优先权日:2010-07-02
标 题:Process for the synthesis of tapentadol and intermediates thereof
发明人:MOTTA GIUSEPPE; VERGANI DOMENICO; BERTOLINI GIORGIO; LANDONI NICOLA
权利人:MOTTA GIUSEPPE; VERGANI DOMENICO; BERTOLINI GIORGIO; LANDONI NICOLA; EUTICALS SPA
摘要:The object of the present invention is a new process for the synthesis of tapentadol, both as free base and in hydrochloride form, which comprises the step of alkylation of the ketone (VII) to yield the compound (VIII), as reported in Diagram 1, with high stereoselectivity due to the presence of the benzyl group as substituent of the amino group. It was surprisingly found that this substitution shifts the keto-enol equilibrium towards the desired enantiomer and amplifies the capacity of the stereocenter present in the compound (VII) to orient the nucleophilic addition of the organometallic compound at the carbonyl towards the desired stereoisomer. This substitution thus allows obtaining a considerable increase of the yields in this step, and consequently allows significantly increasing the overall yield of the entire tapentadol synthesis process. n A further object of the present invention is constituted by the tapentadol free base in solid form, obtainable by means of the process of the invention. n Still another object of the invention is represented by the crystalline forms I and II of the tapentadol free base. n A further object of the present invention is the mixture of the crystalline forms I and II of the tapentadol free base.
专利号:US-2023287032-A1
优先权日:2020-08-14
标 题:Synthesis of fluorinated nucleotides
发明人:CHUNG CHEOL KEUN; LIU ZHIJIAN; MALIGRES PETER E; MAO EDNA; OBLIGACION JENNIFER V; PHILLIPS ERIC M; PIRNOT MICHAEL; POIRIER MARC; SONG ZHIGUO JAKE; WANG TAO
权利人:CHUNG CHEOL KEUN; LIU ZHIJIAN; MALIGRES PETER E; MAO EDNA; OBLIGACION JENNIFER V; PHILLIPS ERIC M; PIRNOT MICHAEL; POIRIER MARC; SONG ZHIGUO JAKE; WANG TAO; MERCK SHARP & DOHME LLC
摘要:The present invention relates to efficient processes useful in the preparation of fluorinated nucleosides, such as (O—{[(2R,3R,4S,5R)-5-(6-amino-9H-purin-9-yl)-4-fluoro-3-hydroxyoxolan-2-yl]methyl}O,O-dihydrogen phosphorothioate, also known as 2′-(S)-fluoro-thio-adenosine monophosphate or 2′-F-thio-AMP. Such fluorinated nucleosides may be useful as a biologically active compound and or as an intermediate for the synthesis of more complex biologically active compounds. The present invention also encompasses intermediates useful in the disclosed synthetic processes and the methods of their preparation.
专利号:US-7294743-B2
优先权日:2003-10-23
标题:Method for synthesis of acrylamide derivatives
发明人:ALGOTSSON MATTIAS; BUSSON PHILIPPE; THEVENIN NICOLAS
权利人:GE HEALTHCARE BIO SCIENCES AB
摘要:The present invention relates to a method for synthesis of an acrylamide derivative, starting with dissolving a salt of a nucleophilic amine in water to form an aqueous solution and desalting said solution with a base, comprising the following steps:n a) addition of dissolved activated acrylic acid derivative to said solution; b) acidification of aqueous phase; and c) extraction of said aqueous phase.